Cure My Disease

Don't miss your cure!

 Log in / Sign up

Shocking discovery? new foot pads aim to boost leg circulation

NCT ID NCT07666828

Knowledge-focused Sponsor: Joey Porter Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 30, 2026 · Updated 2 times

Summary

This study tests three different electrical stimulation foot pad programs in 24 healthy adults to see which one improves blood flow in the legs the most. Participants will use each program once for 30 minutes while blood flow and muscle oxygen are measured. The goal is to find out if two new programs work better than the current standard program.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
neuromuscular electrical stimulation (NMES) foot pad device
What this could lead to
If successful, this could lead to better-designed NMES devices for improving leg circulation in people with poor blood flow.
What could go wrong
This is a small, early study in healthy adults only, so results may not apply to patients with circulation problems. The new programs may not work better than the existing one.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 24 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Jan 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Healthy * Age 18 or over * Ability to communicate in English and provide informed consent Exclusion Criteria: * Lack of capacity to provide informed consent * Electronic implanted device (e.g. cardiac pacemaker) * Pregnancy or intending to become pregnant during the study period * Currently being treated for or have symptoms of an existing deep vein thrombosis (DVT) * Diagnosis of vascular disease or disorder * Terminal illness * Neurological disorders (e.g. epilepsy) * Musculoskeletal injury/disorders (e.g. recent injury or surgery) * Skin conditions (e.g. eczema or open wounds near plantar surface of the foot) * Cardiovascular conditions (e.g. arrhythmia or uncontrolled hypertension) * Diabetes mellitus with neuropathy.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Healthy are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Healthy

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.